These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 13983980)

  • 21. The role of nitric oxide in the modulation of hepatic microcirculation and tissue oxygenation in an experimental model of hepatic steatosis.
    Ijaz S; Yang W; Winslet MC; Seifalian AM
    Microvasc Res; 2005 Nov; 70(3):129-36. PubMed ID: 16203017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preserved direct hepatic insulin action in rats with diet-induced hepatic steatosis.
    Buettner R; Ottinger I; Schölmerich J; Bollheimer LC
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E828-33. PubMed ID: 14722026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Stabilization of hydroxocobalamin in liver extracts].
    Saccani F; Boselli M
    Boll Chim Farm; 1965 Jun; 104(6):362-8. PubMed ID: 5841211
    [No Abstract]   [Full Text] [Related]  

  • 24. Fatty acid composition and development of hepatic lipidosis during food deprivation--mustelids as a potential animal model for liver steatosis.
    Nieminen P; Mustonen AM; Kärjä V; Asikainen J; Rouvinen-Watt K
    Exp Biol Med (Maywood); 2009 Mar; 234(3):278-86. PubMed ID: 19144866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential gene expression profiles in the steatosis/fibrosis model of rat liver by chronic administration of carbon tetrachloride.
    Chung H; Hong DP; Kim HJ; Jang KS; Shin DM; Ahn JI; Lee YS; Kong G
    Toxicol Appl Pharmacol; 2005 Nov; 208(3):242-54. PubMed ID: 16239168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach.
    Hookman P; Barkin JS
    Am J Gastroenterol; 2003 Sep; 98(9):2093-7. PubMed ID: 14499793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of partial hepatectomy on experimental hepatic fibrosis produced by carbon tetrachloride experimental study].
    DE FEO G; PURPURA F
    Arch Ital Anat Istol Patol; 1954; 27(6):530-48. PubMed ID: 14362795
    [No Abstract]   [Full Text] [Related]  

  • 28. Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.
    Harrison SA; Fecht W; Brunt EM; Neuschwander-Tetri BA
    Hepatology; 2009 Jan; 49(1):80-6. PubMed ID: 19053049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of long-term albumin-deficient diet and chronic CC14 poisoning on the submicroscopic picture of rat liver].
    DAVID H; LUNZENAUER K; BARTOK I
    Z Gesamte Inn Med; 1962 Nov; 17():993-9. PubMed ID: 14025297
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anti-steatogenic hepatic action of 5,6-dimethylbenzimidazolyl-cobamide-coenzyme].
    Bergamaschi Dallorso M; Cappa E
    Boll Soc Ital Biol Sper; 1969 Nov; 45(22):1385-8. PubMed ID: 5397287
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antitoxic action of ornithine-aspartic acid mixture on chronic carbon tetrachloride poisoning in young rats].
    SALVATORE F; COZZOLINO D; SCOPPA P
    Boll Soc Ital Biol Sper; 1958 Jun; 34(12):620-2. PubMed ID: 13572551
    [No Abstract]   [Full Text] [Related]  

  • 32. [Fumigant mixtures of dichloroethane & carbon tetrachloride; hazards & prevention].
    DI PORTO A; PADELLARO A
    Folia Med (Napoli); 1959 Mar; 42(3):276-87. PubMed ID: 13653203
    [No Abstract]   [Full Text] [Related]  

  • 33. [Detoxicating and liver-protective action of glutamic acid].
    SANFILIPPO G
    Athena; 1958; 24(1-2):5-10. PubMed ID: 13522483
    [No Abstract]   [Full Text] [Related]  

  • 34. [HYDROXYCOBALAMINE AND GROWTH].
    ARIOLI C; FICHERA M
    Minerva Pediatr; 1965 May; 17():948-52. PubMed ID: 14344290
    [No Abstract]   [Full Text] [Related]  

  • 35. [Protective effect of aspartic acid on experimental hepatic lesions].
    FODOR O; ABEL C; BAN A
    Rev Int Hepatol; 1957; 7(8):611-24. PubMed ID: 13528253
    [No Abstract]   [Full Text] [Related]  

  • 36. [Action of hydroxycobalamine in the prevention of hepatic steatosis due to carbon tetrachloride and the Best diet. (Preliminary communication)].
    STERNIERI E; BERNARDI M; GIAROLI M
    Boll Soc Ital Biol Sper; 1962 Sep; 38():817-8. PubMed ID: 13983980
    [No Abstract]   [Full Text] [Related]  

  • 37. [Action of cyano- and hydroxy-cobalamin on the steatogenic effects of carbon tetrachloride on rat liver as a function of time].
    Giaroli M; Bernardi M; Sternieri E
    Boll Soc Ital Biol Sper; 1965 Mar; 41(5):246-9. PubMed ID: 5876880
    [No Abstract]   [Full Text] [Related]  

  • 38. [The pathogenic mechanism of hepatic steatosis due to carbon tetrachloride].
    Dianzani MU
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1967; 60(1):49-65. PubMed ID: 5620053
    [No Abstract]   [Full Text] [Related]  

  • 39. [The action of aspartate on the hepatic and renal fixation of Co58-labeled vitamin B 12 in experimental chronic carbon tetrachloride poisoning].
    Fodor O; Szantay I; Cotul S; Szabo P
    Stud Cercet Med Interna; 1969; 10(3):263-6. PubMed ID: 5345227
    [No Abstract]   [Full Text] [Related]  

  • 40. [Enzymatic aspects of the biochemical disorders of experimental hepatic steatosis].
    Mafte E; Bîrzu O; Bîcleşeanu C; Catană R
    Fiziol Norm Patol; 1965; 11(6):549-54. PubMed ID: 5885305
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.